Ruben Niesvizky in New York, New York

Additional Medical Specialties Include:
HEMATOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 1985
The Primary Medical Specialty for Ruben Niesvizky is listed as: Medical Oncology
Approximate Years of Experience: 39
PAC (PECOS ID)#: 5294866299
NPI #: 1710074885
NPI Created On: 10/09/2006
NPI Last Updated Listed as: 07/31/2023
Primary Taxonomy Code: 207RH0003X
License Number:
195309
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Bone marrow biopsy and aspiration
3. Vaccine for influenza for administration into muscle, 0.5 ml dosage
4. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
5. Infusion into a vein for therapy, prevention, or diagnosis
6. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
7. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
8. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
9. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
10. Infusion of chemotherapy into a vein up to 1 hour
11. Infusion of chemotherapy into a vein
12. New patient office or other outpatient visit, typically 60 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Established patient office or other outpatient, visit typically 40 minutes
16. Subsequent hospital inpatient care, typically 35 minutes per day
17. Hospital discharge day management, more than 30 minutes
18. Administration of influenza virus vaccine
19. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
20. Injection, darbepoetin alfa, 1 microgram (non-esrd use)